The SEC23B gene helps cells package and move newly made proteins to where they are needed. If it does not work well, the body may have trouble making healthy red blood cells. This can cause a rare inherited anemia called congenital dyserythropoietic anemia type II, with symptoms such as tiredness, pale skin, jaundice, an enlarged spleen, or gallstones. This gene plays an important role in tissues that need steady protein transport to stay healthy.
What is a gene?
Genes are segments of DNA that provide cells with instructions to make molecules or direct processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes take place, where they happen, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To look into this topic more closely, you can read more in the LearnHub.
Overview
SEC23BGene function
What if the gene works
The SEC23B gene helps cells package and move newly made proteins. This supports normal red blood cell development and routine function in many tissues.
Risk
What if the gene does not work
Variants in the SEC23B gene most often cause congenital dyserythropoietic anemia type II, with abnormally formed red blood cells and anemia that can be mild or more marked. Variant severity can influence when symptoms appear and which features show up.
Treatment
What does that mean for your treatment
No SEC23B-specific treatment or drug selection approach is currently established. Management is based on the person’s anemia and iron overload rather than on a distinct medicine choice linked to the SEC23B gene.
Conditions associated with SEC23B
Gene function
What if the gene works
Your cells are always moving newly made proteins to the places where they are needed. The SEC23B gene helps manage this traffic by helping proteins leave the endoplasmic reticulum, the cell area where many proteins are made and folded. This steady transport supports normal cell upkeep and protein release. Understanding what the SEC23B gene does in the body starts with this routine shipping job.
The SEC23B gene helps cells wrap selected proteins into tiny transport sacs called vesicles. These vesicles bud from the endoplasmic reticulum so proteins can continue their trip to the next cell station.
Through its protein, the SEC23B gene helps form the COPII coat, a protein layer that shapes transport carriers. This allows cargo to move from the endoplasmic reticulum toward the Golgi apparatus, the cell's sorting center.
One role of the SEC23B gene is to help the transport coat recognize proteins that are ready to travel. This keeps routine protein delivery organized and supports cells that regularly send proteins out or place them on their surface.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SEC23B gene can weaken the protein, make it less stable, or reduce how well it helps move newly made proteins through the cell’s shipping pathway. This helps explain how SEC23B variants affect protein transport in developing red blood cells. Some variants are milder and leave partial activity, while more severe variants can greatly reduce or stop function. That functional difference can influence whether congenital dyserythropoietic anemia type II appears in a milder form or with earlier, more noticeable features.
How variants are linked to conditions
Pathogenic variants in the SEC23B gene cause congenital dyserythropoietic anemia type II, an inherited condition that can lead to lifelong anemia, jaundice, an enlarged spleen, and gallstones. The link between SEC23B gene variants and congenital dyserythropoietic anemia type II is well established, usually when a person inherits a disease-causing variant from each parent. Other reported SEC23B associations are not as firmly established.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SEC23B-related congenital dyserythropoietic anemia, risk is mainly set by the gene changes inherited from your parents, and lifestyle is not known to meaningfully change the chance of having the condition. Family history can raise the chance, and for future children, risk is higher when both parents carry a SEC23B variant.
Inheritance of SEC23B variants
SEC23B-related conditions are inherited in an autosomal recessive pattern. In practical terms, how SEC23B gene variants are inherited usually means a child needs to receive one changed copy of the SEC23B gene from each parent to be affected. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without the familial variants. Sons and daughters are affected at the same rate.
What does my SEC23B result mean for my family?
For families, a SEC23B result usually matters most in a recessive pattern. Parents, brothers, sisters, and adult relatives may want to know whether they also carry a changed copy, especially if there is a family history of anemia or if relatives are planning children. A child is usually affected only when both parents pass on a changed SEC23B copy.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to this gene, clinicians use genetic testing for SEC23B variants, usually on a blood or saliva sample. A lab reads the DNA code and compares it with the usual sequence to see whether a variant is present, and results may show a pathogenic variant, a benign variant, or an uncertain finding.
When should I consider getting a genetic test?
Consider testing for the SEC23B gene if you or your child has ongoing anemia that started early in life, especially with jaundice, an enlarged spleen, or gallstones. It can also make sense if congenital dyserythropoietic anemia type II runs in your family or was suspected from blood or bone marrow results.
A genetic result is only one part of your health story
A genetic finding can provide meaningful insight, but how much it explains depends on the condition and the type of variant involved. Lifestyle, environment, age, and medical history are among the many factors that shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, moves, or responds to a drug. These differences are common and are one of several factors, along with age, other health conditions, and other medicines, that can shape treatment response.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medication. By looking at the connection between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes affect both how strongly a drug works and how the body processes it. This understanding can support treatment decisions that are more informed and more individualized. More information about this topic is available in the LearnHub.
Drugs influenced by the SEC23B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, how well a medicine is working, or how your health condition may affect treatment, it is a good idea to talk with your doctor or pharmacist.